Helpful tips / 01/12/2019

What are the side effects of Jentadueto?

Common side effects of Jentadueto are:

cough,
sore throat,
sinus pain,
stuffy nose,
upset stomach,
weight gain,
pancreatitis,
diarrhea, and.

How much metformin is in Jentadueto?

JENTADUETO XR 5 mg linagliptin/1000 mg metformin hydrochloride extended-release tablet should be taken as a single tablet once daily.

When is the best time to take Jentadueto?

Take Jentadueto with a meal, unless your doctor tells you otherwise. Swallow the tablet whole and do not crush, chew, or break it. You may have low blood sugar (hypoglycemia) and feel very hungry, dizzy, irritable, confused, anxious, or shaky.

What is Jentadueto 2.5 mg used for?

Jentadueto combines two antihyperglycaemic medicinal products with complementary mechanisms of action to improve glycaemic control in patients with type 2 diabetes: linagliptin, a dipeptidyl peptidase 4 (DPP-4) inhibitor, and metformin hydrochloride, a member of the biguanide class.

Can you take dapagliflozin with metformin?

Dapagliflozin and metformin combination is used together with proper diet and exercise to treat type 2 diabetes. It is also used to lower the risk of hospitalization for heart failure in patients with type 2 diabetes and heart or blood vessel disease.

Can you take metformin and linagliptin together?

Taking them with linagliptin-metformin can cause your blood sugar level to drop too low. The dosages of these drugs may need to be decreased when taken with this medication. This can help reduce the risk of a low blood sugar reaction.

Is jentadueto being recalled?

Jentadueto Recall At the time of publication of this article Jentadueto (linagliptin / metformin) is still on the market and has not been recalled.

What kind of Medicine is Jentadueto for type 2 diabetes?

Jentadueto is a medicine that contains the active substances linagliptin and metformin hydrochloride. It is available as tablets (2.5 mg/850 mg and 2.5 mg/1,000 mg). Jentadueto is used in adults with type 2 diabetes to improve the control of blood glucose (sugar) levels.

What’s the maximum dose of Jentadueto you can take?

If Jentadueto is taken with a sulphonylurea or insulin, the dose of these medicines may need to be lowered, to avoid hypoglycaemia (low blood sugar levels). The maximum dose is 5 mg of linagliptin and 2,000 mg of metformin per day. Jentadueto should be taken with food to reduce stomach problems caused by metformin. How does Jentadueto work?

How many linagliptin and metformin are in Jentadueto tablets?

1. Name of the medicinal product 2. Qualitative and quantitative composition Each tablet contains 2.5 mg of linagliptin and 850 mg of metformin hydrochloride. Each tablet contains 2.5 mg of linagliptin and 1,000 mg of metformin hydrochloride. For the full list of excipients, see section 6.1. 3. Pharmaceutical form Film-coated tablet (tablet).

Is there a generic version of Jentadueto available?

There is currently no generic version of Jentadueto available in the United States, so this can make the it more expensive. Is Jentadueto hard on the kidneys? Jentadueto does not cause kidney damage.

What kind of medication is Jentadueto for type 2 diabetes?

Jentadueto is a combination medication containing linagliptin and metformin. This medication is an add-on to diet and exercise to improve blood sugar control in people with type 2 diabetes. What is Jentadueto?

The dosage of Jentadueto should be individualized on the basis of both effectiveness and tolerability, while not exceeding the maximum recommended dose of 2.5 mg linagliptin/1000 mg metformin hydrochloride (HCl) twice daily. Jentadueto should be given twice daily with meals.

What are the side effects of Jentadueto in adults?

Prompt hemodialysis is recommended [see Warnings and Precautions (5.1) ]. Jentadueto is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus [see Dosage and Administration (2.1) and Clinical Studies (14.1) ].

Is it safe to take Jentadueto with metformin?

Jentadueto should not be used in patients with type 1 diabetes. When linagliptin was added to a sulphonylurea on a background of metformin, the incidence of hypoglycaemia was increased over that of placebo. Sulphonylureas and insulin are known to cause hypoglycaemia.